- 乳癌化疗利弊
- 骨密度与乳腺癌
- NICE 公布 ...
- 为何不见佛陀?
- HER2阳性乳腺癌脑转移的治疗...
- 慎子七篇 答患者问为啥叫w...
- 急性乳腺炎
- 应广大患者要求讨论一下: 乳腺...
- BREAST CONSERVI...
- 人生可以随时开始
- 乳腺癌化疗新进展
- 早期乳腺癌治疗新理念
- 《NCCN临床实践指南(200...
- 中国年增乳腺癌19万例 发病年...
- 乳腺癌术后上肢淋巴水肿的治疗现...
- 医学专业搜索引擎
- 彩超结果乳腺增生伴局部导管扩张...
- 究竟为什么转氨酶高?
- 针对我母亲目前的症状我们该如何...
- 乳腺纤维腺瘤不开刀.还有其他的...
- 小说童话的伪书--- 《...
- 西天灵山仙佛表
- 古代兵法之----古代阵形
- 头脑风暴法
- 男性乳房发育症----学生讲座
- 乳腺钼靶检查与诊断分级
- 年龄与复查---来自医生的忠告
- 绝经后早期乳腺癌患者骨丢失的防...
- 绝经后乳腺癌辅助内分泌治疗
- 三阴性乳腺癌的特点与治疗
- 乳腺癌若干治疗进展
- HER2阳性乳腺癌治疗原则
- 2009年St.Gallen早...
- 《2009年NCCN乳腺癌临床...
- 《2009年NCCN乳腺癌临床...
- 针对共性提问--给大家讲解:2...
- 针对共性提问--给大家讲解:1...
- 什么是乳腺增生症?
- 乳腺癌的早期发现和治疗
- 乳腺癌常见症状
- 致乳腺癌危险因素
- 女性终生坚持锻炼不易患乳腺癌
- 肿块的良恶性判别乳腺方法
- 养成自我检查的好习惯
- 注释索引
- 杂家
- 三道家
- 二墨家
- 儒家
- 答患者问----乳腺癌术后饮食
- 化疗最大的潜在致命性不良反应之...
- 化疗患者粒细胞缺乏感染的治疗
- 认识化疗
- CTCEA 3.0
- 化 疗 发 展 史
- 乳腺癌的基因分型和个体化治疗
- 肿瘤学中常见的各种概念的汇总
- 戏曲艺术的形成
- 少林七十二绝艺
- 形意拳入门
- 中国曲艺
- 宗教音乐3
- 宗教音乐2
- 宗教音乐1
- New Age新纪元音乐
- 35种音乐的分类&解释
- 双侧原发性乳腺癌临床分析
- 国内白蛋白的应用极不恰当:白蛋...
- 白蛋白疗效的荟萃分析
- 白蛋白的合理使用
- 乳腺癌保乳手术
- 内分泌治疗与化学治疗
- 乳腺癌术后5年内约30%的病人...
- 乳腺癌辅助治疗共识
- NSABP B-18
- 21世纪乳腺癌治疗的展望
- 微创-乳腺癌外科治疗的发展方向
- PET在乳腺癌中的应用
- 乳腺X线片与超声比较
- 美国乳腺与肠道外科辅助治疗研究...
- 乳腺癌化疗方案
- 专家点评--从St Galle...
- 新辅助化疗(术前化疗)优点
- 乳房的穿刺针活检有什么优点
- 我市首届乳腺癌患者联谊会
- 基本理念:建档-系统处理-审核...
- Metastasis Detection in Sentinel Lymph Nodes: Comparison of a Limited Widely Spaced (NSABP Protocol B-32) and a Comprehensive Narrowly Spaced Paraffin Block Sectioning Strategy.
- 作者:潘荟丞|发布时间:2009-11-02|浏览量:516次
Departments of *Pathology section signSurgery parallelBiostatistics, University of Vermont daggerVermont Cancer Center double daggerFletcher Allen Health Care, Burlington, VT.
The National Surgical Adjuvant Breast and Bowel Project B-32 trial is examining whether patients with initially negative sentinel lymph nodes (SLNs) who have occult metastases detected on deeper levels and cytokeratin immunohistochemistry stains are at risk for regional or distant metastases. The experimental B-32 protocol was designed to detect metastases larger than 1.0 mm by examining sections approximately 0.5 and 1.0 mm deeper into the paraffin blocks (2 levels; wide spacing). This pilot quality assurance study compares detection rates to a comprehensive protocol designed to detect metastases larger than 0.2 mm (multilevel; narrow spacing). All SLNs were sectioned grossly at close to 2.0 mm and all sections embedded in paraffin blocks. For clinical treatment, a single hematoxylin and eosin section was examined from each block. For 54 cases with 1 to 5 SLNs and all SLNs negative, additional cytokeratin immunohistochemistry sections were evaluated every 0.18 mm through the block until no tissue remained. Twenty of 176 (11.4%) blocks harbored occult metastases; the B-32 protocol detected metastases in 11 blocks (6.3%) and 9 additional blocks (5.1%) with metastases were detected on sections that would not have been evaluated (P=0.002; correlated proportions). Median number of levels examined per block on the comprehensive protocol was 11 (range: 3 to 26); the B-32 protocol was fixed at 2 levels (median 2; range: 1 to 2). Median thickness of node sections in the block was 2.1 mm (range: 0.7 to 4.8 mm) and the modal thickness was 2.3 mm. Although more comprehensive sectioning of SLNs detects additional micrometastases, the data suggest diminishing returns and reduced cost effectiveness for the comprehensive strategy.唐山工人医院腺体外科潘荟丞
TA的其他文章: